Vitrolife

Vitrolife FCF Yield

The Free Cash Flow Yield of Vitrolife (VITR.ST) as of Nov 11, 2026 is 3.59 %. In the previous year, Free Cash Flow Yield was 6.37 % — a change of -43.56% (lower).

FCF Yield

3.59 %

YoY

-43.56%

Last updated:

Free Cash Flow Yield of Vitrolife is 2025 3.59 % . Free Cash Flow Yield of Vitrolife was 2024 6.37 % . It decreases by -43.56% lower compared to the previous year.

The Vitrolife FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
1.32 SEK
Jan 1, 2019
2.55 SEK
Jan 1, 2020
2.63 SEK
Jan 1, 2021
2.51 SEK
Jan 1, 2022
4.29 SEK
Jan 1, 2023
4.98 SEK
Jan 1, 2024
6.37 SEK
Jan 1, 2025
3.59 SEK
The Vitrolife FCF Yield history
YEARFCF YieldYoY
3.59 %-43.56%
6.37 %+27.74%
4.98 %+16.21%
4.29 %+70.57%
2.51 %-4.31%
2.63 %+3.10%
2.55 %+92.66%
1.32 %-43.88%
2.36 %+80.12%
1.31 %-1.98%
1.34 %+24.97%
1.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vitrolife Stock analysis

What does Vitrolife do? Vitrolife AB is a Swedish biotech company specializing in the development and marketing of products for in vitro fertilization (IVF) and regenerative medicine. It was founded in 1994 and has over 390 employees worldwide. The company's main business is IVF, offering a wide range of essential products for IVF treatment such as culture media, devices for semen analysis and preparation, embryo transfer techniques, and products for biopsy examinations and cryopreservation. Vitrolife has a presence in 110 countries and has expanded its market to China where there is a high demand for fertility treatments. The company also offers medical equipment for regenerative treatments. Vitrolife is a leading player in the IVF industry known for its high product quality and innovation. It collaborates with universities and research institutions globally to improve IVF technology and success rates. The company places importance on sustainability and environmental protection, using 100% animal-free ingredients in their culture media and practicing recycling and waste reduction in their production facilities. In summary, Vitrolife offers a wide range of products for IVF and regenerative medicine, with a focus on supporting IVF treatments. The company is a leader in its industry and actively participates in research. It is committed to sustainability and environmental responsibility. Vitrolife is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vitrolife stock

Free Cash Flow Yield of Vitrolife is 3.59 % in 2025.

Free Cash Flow Yield of Vitrolife changed from 6.37 % to 3.59 %, representing a -43.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Vitrolife since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Vitrolife with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Vitrolife

All Key Metrics — Vitrolife